Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27717298

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2016 Nov 10
First author
Eggermont AM

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Jan 26;376(4):399. doi: 10.1056/NEJMc1615564.
    note
    Source null
    related pmid
    28121506
    relationship
    Comment in
  2. citation
    N Engl J Med. ;376(4):398. doi: 10.1056/NEJMc1615564.
    note
    Source null
    related pmid
    28125193
    relationship
    Comment in
  3. citation
    N Engl J Med. ;376(4):398-9. doi: 10.1056/NEJMc1615564.
    note
    Source null
    related pmid
    28125194
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Apr 4;380(14):1374-1376. doi: 10.1056/NEJMc1902228.
    note
    Source null
    related pmid
    30943345
    relationship
    Comment in
  5. citation
    N Engl J Med. 2018 Nov 29;379(22):2185. doi: 10.1056/NEJMx180040.
    note
    Source null
    related pmid
    31442371
    relationship
    Erratum in

Authors and identifiers

  1. name
    Eggermont AM
    type
    Author
  2. name
    Chiarion-Sileni V
    type
    Author
  3. name
    Grob JJ
    type
    Author
  4. name
    Dummer R
    type
    Author
  5. name
    Wolchok JD
    type
    Author
  6. name
    Schmidt H
    type
    Author
  7. name
    Hamid O
    type
    Author
  8. name
    Robert C
    type
    Author
  9. name
    Ascierto PA
    type
    Author
  10. name
    Richards JM
    type
    Author
  11. name
    Lebbé C
    type
    Author
  12. name
    Ferraresi V
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Eggermont AM
    type
    Author
  2. name
    Chiarion-Sileni V
    type
    Author
  3. name
    Grob JJ
    type
    Author
  4. name
    Dummer R
    type
    Author
  5. name
    Wolchok JD
    type
    Author
  6. name
    Schmidt H
    type
    Author
  7. name
    Hamid O
    type
    Author
  8. name
    Robert C
    type
    Author
  9. name
    Ascierto PA
    type
    Author
  10. name
    Richards JM
    type
    Author
  11. name
    Lebbé C
    type
    Author
  12. name
    Ferraresi V
    type
    Author
bibliography ids
  1. nci-bib-108dee70d02e89291fbf6b34
book metadata
content sha256
034948f0d6b1539f295c033b9aa5194718d096523969aff7ad1e313fe1834891
document type
citation
dois
  1. 10.1056/NEJMoa1611299
electronic publication date
display
2016 Oct 7
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27717298
immutable id
pubmed:27717298@034948f0d6b1539f295c033b9aa5194718d096523969aff7ad1e313fe1834891
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
19
name
The New England journal of medicine
nlm unique id
0255562
pages
1845-1855
volume
375
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Jan 26;376(4):399. doi: 10.1056/NEJMc1615564.
    note
    Source null
    related pmid
    28121506
    relationship
    Comment in
  2. citation
    N Engl J Med. ;376(4):398. doi: 10.1056/NEJMc1615564.
    note
    Source null
    related pmid
    28125193
    relationship
    Comment in
  3. citation
    N Engl J Med. ;376(4):398-9. doi: 10.1056/NEJMc1615564.
    note
    Source null
    related pmid
    28125194
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Apr 4;380(14):1374-1376. doi: 10.1056/NEJMc1902228.
    note
    Source null
    related pmid
    30943345
    relationship
    Comment in
  5. citation
    N Engl J Med. 2018 Nov 29;379(22):2185. doi: 10.1056/NEJMx180040.
    note
    Source null
    related pmid
    31442371
    relationship
    Erratum in
outcomes validated
false
pmid
27717298
provenance
batch id
d649bcb2d98dbbacd53c
provider
NCBI PubMed ESummary
record sha256
898fffb584c1b711f68506d08848e963a708436dc7c6db4a0b6fcddd338a5c09
response sha256
26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
retrieved at
2026-09-09T23:47:20.761544+00:00
publication date
display
2016 Nov 10
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27717298/
title
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.

Preserved source evidence · Not medical advice